| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 0.92 | 0.22 | 0.10 | 0.32 |
| Receivables | 3.98 | 5.40 | 5.96 | 3.30 |
| Inventory | 7.79 | 8.49 | 8.74 | 7.83 |
| Other | — | — | — | — |
| 13.02 | 14.53 | 15.07 | 11.79 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 0.92 | 1.54 | 1.68 | 1.48 |
| ST’ Debt | 4.99 | 6.58 | 6.82 | 4.59 |
| Other | 1.50 | 1.05 | 0.15 | 0.23 |
| 10.14 | 11.41 | 10.69 | 8.37 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 6.15 | 3.90 | — | — |
—
|
| ’25 | 4.80 | 5.46 | 2.95 | 6.49 |
19.71
|
| ’24 | 4.89 | 4.35 | 2.54 | 6.17 |
17.95
|
| ’23 | 5.05 | 4.06 | 1.92 | 6.77 |
17.80
|
| ’22 | 5.80 | 4.42 | 2.26 | 5.57 |
18.05
|
| ’22 | — | — | — | — |
18.05
|
| ’21 | 6.60 | 5.71 | 5.18 | 6.59 |
24.09
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.24 | 2.30 | — | — |
—
|
| ’25 | 0.97 | 0.74 | 0.59 | (2.47) |
(0.17)
|
| ’24 | (0.77) | 0.88 | 0.75 | (2.14) |
(1.27)
|
| ’23 | (1.37) | 0.01 | 0.92 | (0.78) |
(1.22)
|
| ’22 | 0.00 | 0.30 | 0.88 | 1.18 |
2.37
|
| ’22 | — | — | — | — |
2.37
|
| ’21 | (1.42) | 0.80 | (0.59) | (2.51) |
(3.71)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.21 | 2.30 | — | — |
—
|
| ’25 | 0.95 | 0.72 | 0.56 | (2.13) |
0.10
|
| ’24 | (0.92) | 0.76 | 0.73 | (2.16) |
(1.60)
|
| ’23 | (1.42) | (0.03) | 0.88 | (0.86) |
(1.44)
|
| ’22 | (0.01) | 0.22 | 0.86 | 1.14 |
2.21
|
| ’22 | — | — | — | — |
2.37
|
| ’21 | (1.47) | 4.30 | (0.63) | (2.53) |
(0.33)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.15) | (0.22) | — | — |
—
|
| ’25 | (0.20) | (0.10) | (0.31) | (0.43) |
(1.01)
|
| ’24 | (0.30) | (0.20) | (0.50) | 0.30 |
(0.70)
|
| ’23 | 0.20 | (0.10) | (0.50) | 0.20 |
(0.10)
|
| ’22 | (0.40) | (1.00) | (1.20) | (0.10) |
(2.20)
|
| ’22 | (3.60) | 1.20 | (1.40) | — |
(0.22)
|
| ’21 | — | — | — | — |
(2.01)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡ | 3.30 | 10.40 | 4.30 | 3.37 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 15.00 | 30.90 | 22.00 | 12.70 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 58 | 57 | 52 | 52 | — | — | — |
Employees
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.31 | 0.35 | 0.38 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.05 | 17.80 | 17.95 | 19.71 | — | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.39% | 18.30% | 20.06% | 18.22% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.47) | (0.23) | (1.50) | (2.53) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (8.13%) | (1.32%) | (8.35%) | (12.84%) | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.47) | (0.23) | (1.50) | (2.53) | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.38 | 0.28 | 0.35 | 0.64 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.94 | 9.12 | 7.68 | 7.37 | — | — | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.22) | (0.10) | (0.70) | (1.01) | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.25 | (0.63) | (0.55) | (0.06) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | (0.11) | (0.14) | 0.10 | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.25 | (0.74) | (0.69) | 0.04 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.30 | 1.91 | 4.58 | 3.20 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.30 | 1.95 | 2.34 | 2.67 | — | — | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 0.32 | 2.30 | 0.72 | 0.49 | — | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 0.00 | 10.99 | 1.37 | 1.37 | — | — | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.65 | 2.56 | 1.10 | 0.85 | — | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (46.86) | (31.61) | (12.26) | 169.42 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.37 | (1.22) | (1.27) | (0.17) | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.16) | (0.22) | (0.33) | 0.27 | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.37 | (1.44) | (1.60) | 0.10 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.00 | 2.88 | 3.12 | 4.39 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.74 | 5.52 | 6.58 | 7.17 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.60 | 4.60 | 6.36 | 7.07 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.75 | 3.73 | 10.70 | 8.56 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (12.60%) | (1.51%) | (7.67%) | (11.25%) | — | — | — |
ROA
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00% | (2.99%) | (2.24%) | (8.20%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 133.79% | (10.63%) | (25.06%) | (32.89%) | — | — | — |
ROE
|
Yunhong Green CTI Ltd. (YHGJ), a small-cap eco-packaging innovator, has weathered brutal revenue declines from $64 million in 2016 to about $18 million in 2024, slashing its workforce by 89% to just 52 employees. This lean pivot has supercharged efficiency, with revenue per employee soaring to $345,000 and gross margins rebounding 48% to 20.1%, signaling smarter operations and a focus on biodegradable, plant-based foams amid rising green regulations.
Despite ongoing losses—$1.5 million net in 2024—and volatile cash burns, the balance sheet shines: debt slashed 72%, equity ballooned 187% to boost book value per share 140%, and valuations look dirt-cheap at 0.72x sales and 1.37x book, far below peers in the ESG-fueled bioplastics space.
Analysts are unanimously bullish, targeting over 2,250% upside, betting on revenue rebounds, margin expansion to 25%+, and profitability by 2026 as green tailwinds like EU bans and U.S. subsidies kick in. With capex restrained and shares concentrated, YHGJ could be a phoenix rising—or a cautionary trap. Dive into the full analysis for the numbers that could make or break this turnaround story.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.